Menchu Ong
Anatomic Pathology & Clinical Pathology · Shreveport, LANPI 1821234378
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 22 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by AstraZeneca at 28.9% of the total. Among anatomic pathology & clinical pathology clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 22 payments — averaging $27.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$173
- Sanofi$152
- Astellas Pharma US Inc$55
- Amgen$53
- Tempus AI, Inc$43
- Pharmacyclics LLC, An Abbvie Company$42
- plus $81 from 2 others
What the payments were for
- Food & beverage$598100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 3 | $173 |
| Sanofi | 7 | $152 |
| Astellas Pharma US Inc | 3 | $55 |
| Amgen | 2 | $53 |
| Tempus AI, Inc | 2 | $43 |
| Pharmacyclics LLC, An Abbvie Company | 2 | $42 |
| Sanofi-aventis U.S. LLC | 2 | $42 |
| Roche Diagnostics Corporation | 1 | $39 |
How this compares
$598 in reported general payments places this provider in the 90th percentile of 132 anatomic pathology & clinical pathology providers in Louisiana.
See all anatomic pathology & clinical pathology providers in Louisiana →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other anatomic pathology & clinical pathology in Shreveport
- Aaron CotrellShreveport$8K
- Fredric SiskronShreveport$1K
- Rusella MirzaShreveport$959
- Fleurette AbreoShreveport$510
- Ammoura IbrahimShreveport$426
- Susan VeillonShreveport$421
- Kshitij AroraShreveport$386
- Xin GuShreveport$367
- Adaugo NwangumaShreveport$205
- Bernadette McLarenShreveport$196
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.